Rimantadine hydrochloride (alpha-methyl-ladamantane methylamine hydrochloride) inhibits influenza A replication in vitro (14, 20) and is active against influenza A infections in vitro (16, 22) . Previously, it has been suggested that the antiviral spectrum and mechanism of action of rimantadine are similar to its structural analog amantadine hydrochloride (14) . However, most studies agree that rimantadine is more effective against influenza than amantadine in tissue culture (20, 21) , animal (18) , and clinical trials (22) .
Studies with amantadine have determined that the antiviral effect of the drug against influenza in vitro results from either inhibition of penetration of the virus into the host cell (3, 7) or suppression of the uncoating of the virus particles (9) . Previously, studies in our laboratory concluded that rimantadine inhibits influenza replication in vitro by acting at a step in the viral replicative cycle preceding the primary transcription of the influenza virus genome (10) .
The uncoating process in poxvirus replication has been analyzed by using highly purified virus preparations and noting an increased sensitivity of poxvirus DNA to DNase with time after infection (8) . Removal of the outer envelope from influenza virus is the primary step in its uncoating, and the resulting helical nucleocapsid is able to participate in early macromolecular synthesis (11) . In contrast to the ribonucleoproteins of paramyxoviruses (2), the ribonucleoproteins of orthomyxoviruses are sensitive to digestion by RNase (4, 15 (Table 1) , wheres nearly all of influenza virus acid-insoluble 3P radioactivity was recovered after similar treatment (Table 1) . Therefore, by freezing and thawing MDCK cultures infected with 3P-labeled A/WSN at various times after infection, only the labeled RNA from virions that were uncoated would be susceptible to digestion by RNases A and T1, allowing the kinetics of uncoating to be examined.
After an initial lag period of approximately 15 to 20 min, uncoating of influenza virus proceeds linearly until 90 min after infection (Fig. 1) . The total amount of virus uncoated by 90 min after infection was nearly 50% of the adsorbed inoculum. As a control (not shown), samples not treated with RNases A and T1 showed a uniformly high recovery of acid-insoluble RNA, indicating that influenza RNA is extremely stable in cell culture.
Previous studies in our laboratory on the effect of rimantadine on influenza virus (HON1) replication in MDCK celLs showed that ma inhibition ofvirus replication without any visible cytotoxicity occurred at a drug concentration of 50 ,ug/ml (10) . This concentration of rimantadine significantly (P < 0.01, Student's t test) inhibited the uncoating of influenza virus when added immediately after the virus adsorption period (Fig. 1) . By 90 min after infection, only 10% of the adsorbed inoculum had uncoated in cultures containing rimantadine, compared with 50% in control cultures. When the drug concentration was reduced to 25 ,ug/ml, 24% of the adsorbed inoculum uncoated by 90 min after infection.
Virus may be passaged in the presence of neutral red and rendered photosensitive (13) , and the loss of photosensitivity can be used as an indicator of uncoating. By this method, Kato and Eggers (9) Examination of the kinetics of uncoating in influenza virus revealed a lag of 15 to 20 min after the viral adsorption period before uncoated virus could be detected. Since influenza penetration appears to be accomplished by engulfment or micropinocytosis (19) , the observed lag before detection of uncoating might be interpreted as the time in which the penetrated virus enclosed by the pinocytotic vacuole is still intact with the viral envelope protecting the RNA from digestion by exogenous RNase. The recovery of acidinsoluble radioactive counts in samples not treated with exogenous ribonuclease showed minimal variation throughout the 120-min uncoating assay. Thus, influenza RNA in its ribonucleoprotein complex appears to be insensitive to digestion by cellular RNases in the early stages after infection. These results are in agreement with Scholtissek et al. (17) , who reported that, in contrast to cellular RNA, both virion and complementary viral RNA are completely stable during a 90-min chase period.
At present, the biochemical nature of the uncoating process in influenza virus infections is not well understood. Recently, studies with influenza recombinants have determined that the gene coding for M protein influences sensitivity or resistance to amantadine (12) , indicating a possible association of the M protein with the process inhibited by amantadine. Chloroquine is another drug that is reported to inhibit the uncoating of myxoviruses, with the proposed mechanism of action being the stabilization of lysosomal membranes (6) . Further examination of the biochemical nature of the uncoating process in influenza is necessary to determine the exact mechanism by which rimantadine inhibits uncoating.
